Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients
about
Multifaceted role of clay minerals in pharmaceuticalsStructural characterization and thermal and chemical stability of bioactive molecule-hydrotalcite (LDH) nanocomposites.Cellular uptake pathways of sepiolite nanofibers and DNA transfection improvement.Inorganic matrices: an answer to low drug solubility problem.Clay: new opportunities for tissue regeneration and biomaterial design.Antimicrobial clay-based materials for wound care.Carmellose Mucoadhesive Oral Films Containing Vermiculite/Chlorhexidine Nanocomposites as Innovative Biomaterials for Treatment of Oral Infections.Physicochemical characterization of sterilized muds for pharmaceutics/cosmetics applications.High-Throughput Preparation of New Photoactive Nanocomposites.Sepiolite as a New Nanocarrier for DNA Transfer into Mammalian Cells: Proof of Concept, Issues and Perspectives.Chemical analysis and in vitro UV-protection characteristics of clays traditionally used for sun protection in South Africa.Rationalization of liquid assisted grinding intercalation yields of organic molecules into layered double hydroxides by multivariate analysisApplication of montmorillonite in bentonite as a pharmaceutical excipient in drug delivery systemsCharacterization and evaluation of hydrothermally influenced clayey sediments from Caldeiras da Ribeira Grande fumarolic field (Azores Archipelago, Portugal) used for aesthetic and pelotherapy purposesCorrelation between Electrochemical Impedance Spectroscopy and Structural Properties of Amorphous Tunisian Metanacrite Synthetic Material
P2860
Q28817909-744A852C-52F7-46C5-90DA-0F8922467AB1Q30656468-949F9C93-2C4E-49F6-B36F-25AFD5D4F8D9Q33911874-DE82752E-6372-45F3-B3CD-0AE17748AFDBQ38051672-A15BACC0-A61B-4FAB-B6E4-A30E03E16B14Q38110691-7ABA2706-3307-467B-84CD-FBD8CCF6ED03Q38217503-A0A58088-C5FA-489F-BD79-8F83149258A0Q40638587-322485C5-1050-4D22-9876-F19B60B8727CQ47208016-91ACD68F-4672-47DF-8152-85792D19835AQ48043001-6C943890-89D8-4AEE-BF6B-B12C23DBDC32Q49500035-DD3FC7F8-7A4C-4522-9739-B7C8FBBE8D4AQ50491467-C40A6433-0023-4271-A662-2A8D759FF616Q57352217-4F76472B-29B6-44BA-B1B6-16DF2E8B1DA6Q57353641-D8F5B302-4DEA-4ECF-B0D9-F7BA6E471337Q57868530-F22BD105-3D76-48FB-B2F9-871705B52143Q59046789-562117CD-957D-4499-87FC-91B4CA672F1F
P2860
Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients
description
im Februar 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2010
@uk
name
Clay and non-clay minerals in ...... es Part II. Active ingredients
@en
Clay and non-clay minerals in ...... es Part II. Active ingredients
@nl
type
label
Clay and non-clay minerals in ...... es Part II. Active ingredients
@en
Clay and non-clay minerals in ...... es Part II. Active ingredients
@nl
prefLabel
Clay and non-clay minerals in ...... es Part II. Active ingredients
@en
Clay and non-clay minerals in ...... es Part II. Active ingredients
@nl
P1433
P1476
Clay and non-clay minerals in ...... es Part II. Active ingredients
@en
P2093
M. Isabel Carretero
Manuel Pozo
P304
P356
10.1016/J.CLAY.2009.10.016
P577
2010-02-01T00:00:00Z